Why is Clearpoint Neuro, Inc. ?
- OPERATING CASH FLOW(Y) Lowest at USD -25.72 MM
- ROCE(HY) Lowest at -149.72%
- DEBT-EQUITY RATIO (HY) Highest at 148.59 %
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 57.96%, its profits have fallen by -35.1%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Clearpoint Neuro, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at USD -17.34 MM
Highest at 2.05 times
Fallen by -2.96% (YoY
Highest at USD 12.13 MM
Lowest at USD -25.72 MM
Lowest at -149.72%
Highest at 148.59 %
Lowest at 5.85 times
Highest at USD 1.38 MM
Lowest at USD -7.37 MM
Lowest at USD -9.54 MM
Lowest at USD -9.55 MM
Lowest at USD -0.32
Here's what is working for Clearpoint Neuro, Inc.
Inventory Turnover Ratio
Net Sales (USD MM)
Net Sales (USD MM)
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Depreciation (USD MM)
Here's what is not working for Clearpoint Neuro, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Interest Paid (USD MM)
Debt-Equity Ratio
Operating Cash Flows (USD MM)
Interest Paid (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debtors Turnover Ratio






